Three-Month Safety and Efficacy Outcomes for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™)
, Faustino Vidal-Aroca 3, Marina Montemagni 4, Claudio Xompero 4, Gaetano Fioretto 4 and Ciro Costagliola 4
Mohamed A. Hamid
Round 1
Reviewer 1 Report
In this study authors aimed to show the 3 months safety and efficacy of the SING ITM telescope in 24 patients. They concluded the this new device delivers lower endothelial cell loss than the first generation of the telescope but showing similar visual acuity outcomes.
Congratulations to the authors for the work. I would suggest only two minor points:
1.- I would show in figures 1-3 the mean values in the graphs.
2.- I would use the acronyms:
best-corrected distance visual acuity: CDVA
best-corrected distance near visual acuity: CDNVA
Author Response
We thank Reviewer 1 for the revision and the positive feedback. We have modified the manuscript as suggested. Please see the manuscript in tracked-change mode.
Reviewer 2 Report
I commend the authors for conducting this important study on the newer generation of IMT. They have shown that the improved design yielded more favorable anatomical outcomes while maintaining the same functional improvement previously reported with the original design. Long-term follow-up is especially important to confirm less rates of corneal decompensation requiring keratoplasty. The manuscript is well written and I recommend it be published in its current form.
Author Response
We thank Reviewer 2 for the revision and for the positive feedback. We agree that the long-term follow-up, which we are already working on, will allow us to verify the efficacy and safety of the SING IMTTM telescope. making our preliminary data even more robust. We have, additionally, corrected some typos and added the mean values as suggested by the other reviewer in the figures 1-3.
Author Response File: 
Author Response.pdf
